System Designed to Reduce the Incidence of Positive Margins or Cancer Left Behind After Breast Cancer Surgery CairnSurgical, Inc., an innovator striving to make breast cancer surgery more precise
Dartmouth cancer researchers' cancer surgery innovation named Product of Year nhbr.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from nhbr.com Daily Mail and Mail on Sunday newspapers.
Five New Hampshire firms to vie for Product of the Year honors nhbr.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from nhbr.com Daily Mail and Mail on Sunday newspapers.
Posted on 455
CairnSurgical, Inc., an innovator striving to make breast cancer surgery more precise, announced today that the first patient has been treated in its U.S. pivotal trial of the Breast Cancer Locator (BCL) System at Massachusetts General Hospital. The BCL System is designed to eliminate guesswork in breast cancer surgery by providing a blueprint of the tumor and a surgical guide to achieve clear margins.
“We are committed to participating in clinical research with the potential to improve outcomes for our patients with breast cancer,” said Suzanne Coopey, MD, Massachusetts General Hospital, who performed the first BCL case. “We are very interested in evaluating whether this new approach to guiding the surgeon to tumor margins can make breast cancer surgery more accurate and reduce the need for additional surgery for positive margins.”